drugset / Trial / NCT02194361

Efficacy of a Standardised Bilberry Extract in Improving the Night Vision of Healthy Volunteers

NCT02194361 ↗

Phase 2 Completed 119 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

Study to determine the Efficacy of Standardised Bilberry Extract in improving the night vision and to evaluate its tolerability and safety.

Timeline

Start
1999-12
Primary completion
2000-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bilberry extract Unknown 160 mg —

Indications

No indication recorded.